COVID-19 and kidney damage


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

The review provides data on the frequency and causes of the onset and development of acute kidney injury (AKI) in covid-19. The review of the available scientific information regarding the onset and/or progression of chronic kidney disease (CKD) in covid-19 is presented, and the rare forms of kidney damage that can develop with covid-19 are discussed in detail. attention is paid to aspects of etiopathogenesis and clinical picture of kidney damage in covid-19. when writing the article, the authors globally did not address the issues of treating renal pathology formed during covid-19, since it is currently mainly reduced, on the one hand, to the treatment of a specific form of kidney disease, and on the other hand, to the treatment of coronavirus infection directly. Understanding the processes of alteration of kidney tissue cells in this disease may help to determine approaches to the prevention of kidney damage and the restoration of kidney function in patients with covid-19 in the future.

Full Text

Restricted Access

About the authors

Larisa V. Mikhailova

Immanuel Kant Baltic Federal University

Email: mihalysa@mail.ru
Cand. Sci. (Med.), Associate Professor at the Department of Therapy, Medical Institute

Dmitry O. Sheleg

Immanuel Kant Baltic Federal University

Email: sch994@rambler.ru
Teaching Assistant at the Department of Therapy, Medical Institute

Robert S. Bogachev

Immanuel Kant Baltic Federal University

Email: robcm@rambler.ru
Dr. Sci. (Med.) iences, Professor, Head of the Department of Therapy, Medical Institute

References

  1. Liu Y.F, Zhang Z, Pan X.L., et al. The chronic kidney disease and acute kidney injury involvement in COVID-19 pandemic: A systematic review and meta-analysis. PLoS One. 2021;16(1):e0244779. [Published 2021 Jan 5]. doi: 10.1371/journal.pone.0244779.
  2. Kunutsor S.K., Laukkanen J.A. Renal complications in COVID-19: a systematic review and meta-analysis. Ann. Med. 2020;52(7):345-53. Doi: 10. 1080/07853890.2020.1790643. [Epub 2020 Jul 10. PMID: 32643418].
  3. Henry B.M., Lippi G. Chronic kidney disease is associated with severe coronavirus disease 2019 (COVID-19) infection. Int. Urol. Nephrol. 2020;52:1193-94. https://doi.org/10.1007/s11255-020-02451-9.
  4. Qi F., Qian S., Zhang S., Zhang Z. Single cell RNA sequencing of 13 human tissues identify cell types and receptors of human coronaviruses. Biochem. Biophys. Res. Commun. 2020;526(1):135-40, Doi: 10.1016/ j.bbrc.2020.03.044.
  5. Pan X.-W., Xu D., Zhang H., et al. Identification of a potential mechanism of acute kidney injury during the COVID-19 outbreak: A study based on singlecell transcriptome analysis. Intens. Care Med. 2020;46(6): 1114-16. doi: 10.1007/s00134-020-06026-1.
  6. Diao B., Feng Z., Wang C., et al. Human Kidney is a Target for Novel Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). Infection. MedRxiv. 2020. doi: 10.1101/2020.03.04.20031120.
  7. Su H., Yang M., Wan C., et al. Renal histopathological analysis of 26 postmortem findings of patients with COVID-19 in China. Kidney Int. 2020. doi: 10.1016/j.kint.2020.04.003.
  8. Cheng Y., Luo R., Wang K., et al. Kidney disease is associated with in-hospital death of patients with COVID-19. Kidney Int. 2020:1-10. Doi: 10.1016/ j.kint.2020.03.005.
  9. Li., Wu M., Yao J., et al. Caution on kidney dysfunctions of COVID-19 patient. 2020. doi: 10.1101/2020.02.08.20021212.
  10. Li X, Geng M, Peng Y, et al. Molecular immune pathogenesis and diagnosis of COVID-19. J. Pharm. Anal. 2020;10(2):102-8. Doi: 10.1016/ j.jpha.2020.03.001.
  11. Petejova N., Martinek A. Acute kidney injury due to rhabdomyolysis and renal replacement therapy: A critical review. Crit. Care. 2014; 18. Doi: 10.1186/ cc13897.
  12. Chu K.H., Tsang W.K., Tang C.S., et al. Acute renal impairment in coronavirusassociated severe acute respiratory syndrome. Kidney Int. 2005;67:698-705. doi: 10.1111/j.1523-1755.2005.67130.x.
  13. Del Vecchio L., Locatelli F. Hypoxia response and acute lung and kidney injury: possible implications for therapy of COVID-19. Clin. Kidney J. 2020;13(4):494-99.
  14. Batlle D., Soler M.J., Sparks M.A., et al. Acute Kidney Injury in COVID-19: Emerging Evidence of a Distinct Pathophysiology. J. Am. Soc. Nephrol. 2020;31:1380-83. doi: 10.1681/ASN.2020040419.
  15. Kuppalli K., Rasmussen A.L. A glimpse into the eye of the COVID-19 cytokine storm. EBioMedicine. 2020;55:102789. doi: 10.1016/j.ebiom.2020.102789.
  16. Guan W., Ni Z., Hu Y., et al. Clinical characteristics of coronavirus disease 2019 in China. N. Engl. J. Med. 2020;382:1708-20. Doi: 10.1056/ NEJMoa2002032.
  17. Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2727;395:577-13. Doi: 10.1016/ S0140-6736(20)30211-7.
  18. Chen T., Wu D., Chen H., et al. Clinical characteristics of 113 deceased patients with Coronavirus disease 2019: retrospective study. BMJ. 2020. 368:m1091. 10.1136/bmj.m1091.
  19. Arentz M., Yim E., Klaff L., et al. Characteristics and outcomes of 21 critically ill patients with covid-19 in Washington state. JAMA. 2020;323:1612-14. doi: 10.1001/jama.2020.4326.
  20. Hirsch J.S., Ng J.H., Ross D.W., et al. Acute Kidney Injury in Patients Hospitalized with Covid-19. Kidney Int. 2727;98:279-18. Doi: 10.1016/j. kint.2020.05.006.
  21. Coca A., Burballa C., Centellas-Perez F.J., et al. Outcomes of COVID-19 Among Hospitalized Patients With Non-dialysis CKD. Front. Med. (Lausanne). 2020;7:615312. [Published2020Dec 3]. doi: 10.3389/fmed.2020.615312.
  22. Pei G., Zhang Z, Peng J., et al. Renal involvement and early prognosis in patients with COVID-19 pneumonia. J. Am. Soc. Nephrol. 2020;31:1157-65. doi: 10.1681/ASN.2020030276.
  23. Narayanan M. The many faces of infection in CKD: evolving paradigms, insights, and novel therapies. Adv. Chronic. Kidney Dis. 2019;26:5-7. doi: 10.1053/j.ackd.2018.10.001.
  24. Dalrymple L.S., Go A.S. Epidemiology of acute infections among patients with chronic kidney disease. Clin. J. Am. Soc. Nephrol. 2008;3:1487-93. doi: 10.2215/CJN.01290308.
  25. Syed-Ahmed M., Narayanan M. Immune dysfunction and risk of infection in chronic kidney disease. Adv. Chronic. Kidney Dis. 2019;26:8-15. doi: 10.1053/j.ackd.2019.01.004.
  26. Litjens N.H., van Druningen C.J., Betjes M.G. Progressive loss of renal function is associated with activation and depletion of naive T lymphocytes. Clin. Immunol. 2006;118:83-91. doi: 10.1016/j.clim.2005.09.007.
  27. Williamson E.J., Walker A.J., Bhaskaran K. Factors associated with COVID-19-related death using Open SAFELY. Nature. 2020;584(7821): 430-36.
  28. Cummings M.J., Baldwin M.R., Abrams D. Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study. Lancet. 2020;395(10239):1763-70.
  29. Gansevoort R.T., Hilbrands L.B. CKD is a key risk factor for COVID-19 mortality. Nat. Rev. Nephrol. 2020;26:1-2.
  30. Anding K., Gross P., Rost J.M., et al. The influence of uraemia and haemodialysis on neutrophil phagocytosis and antimicrobial killing. Nephrol. Dial. Transplant. 2773;18:2766-63. doi: 17.1793/ndt/ gfg330.
  31. Ando M., Shibuya A., Tsuchiya K., Akiba T., Nitta K. Reduced expression of Toll-like receptor 4 contributes to impaired cytokine response of monocytes in uremic patients. Kidney Int. 2006;70(2):358-62.
  32. Vaziri N.D. Oxidative stress in uremia: nature, mechanisms, and potential consequences. Semin. Nephrol. 2004;24:469-73. doi: 10.1016/.semnephrol.2004.06.026.
  33. Goligorsky M.S. Pathogenesis of endothelial cell dysfunction in chronic kidney disease: a retrospective and what the future may hold. Kidney Res. Clin. Pract. 2015;34:76-82. Doi: 10.1016/ j.krcp.2015.05.003.
  34. Abbate M., Zoja C., Remuzzi G. How does proteinuria cause progressive renal damage? J. Am. Soc. Nephrol. 2006;17:2974-84. Doi: 10.1681/ ASN.200604037.
  35. Ng J.H., Hirsch J.S., Hazzan A., et al. Outcomes Among Patients Hospitalized With COVID-19 and Acute Kidney Injury. AJKD. 2021;77(2). Doi link: https://doi.org/10.1053/j.ajkd.2020.09.002
  36. Flythe J.E., Assimon M.M., Tugman M.J., et al. Characteristics and Outcomes of Individuals With Pre-existing Kidney Disease and COVID-19 Admitted to Intensive Care Units in the United States. Am. J. Kidney Dis. 2021;77(2):1 90-203.e1. doi: 10.1053/j.ajkd.2020.09.003.
  37. Kang S.H., Kim S.W., Kim A.Y., et al. Association between Chronic Kidney Disease or Acute Kidney Injury and Clinical Outcomes in COVID-19 Patients. J. Korean Med. Sci. 2020;35(50):e434. doi: 10.3346/jkms.2020.35. e434. [PMID: 33372426; PMCID: PMC7769703].
  38. James M.T., Grams M.E., Woodward M., et al. A meta-analysis of the association of estimated GFR, albuminuria, diabetes mellitus, and hypertension with acute kidney injury. Am. J. Kidney Dis. 2015;66:602-12. Doi: 10.1053/ j.ajkd.2015.02.338.
  39. Wu VC, Huang TM, Lai CF, Shiao CC, Lin YF, Chu TS, et al. Acute-on-chronic kidney injury at hospital discharge is associated with long-term dialysis and mortality. Kidney Int. 2011;80:1222-30. doi: 10.1038/ki.2011.259.
  40. Nuzzo D., Picone P. Potential neurological effects of severe COVID-19 infection. Neurosci. Res. 2020;158:1-5.
  41. Sterne J.A.C., Murthy S., Diaz J.V. Association between administration of systemic corticosteroids and mortality among critically ill patients with COVID-19: a meta-analysis. JAMA. 2020;324(13):1-13.
  42. Wu J., Li J., Zhu G. Clinicalfeatures of maintenance hemodialysis patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. Clin. J. Am. Soc. Nephrol 2020;15(8):1139-45.
  43. Corbett R.W., Blakey S., Nitsch D. Epidemiology of COVID-19 in an urban dialysis center. J. Am. Soc. Nephrol 2020;31(8):1815-23.
  44. Basile C., Combe C., Pizzarelli F., et al. Recommendations for the prevention, mitigation and containment of the emerging SARS-CoV-2 (COVID-19) pandemic in haemodialysis centres. Nephrol. Dial. Transplant. 2020; 35:737-41.
  45. Rombola G., Heidempergher M., Pedrini L., et al. Practical indications for the prevention and management of SARS-CoV-2 in ambulatory dialysis patients: lessons from the first phase of the epidemics in Lombardy. J. Nephrol. 2020;33:193-96.
  46. Hoilat G.J., Das G., Shahnawaz M., et al. COVID-19 induced collapsing glomerulopathy and role of APOL1. QJM. 2020 Dec 26. doi: 10.1093/qjmed/ hcaa335.
  47. Kissling S., Rotman S., Gerber C., et al. Collapsing glomerulopathy in a COVID-19 patient. Kidney Int. 2020;98:228-31.
  48. Peleg Y., Kudose S., D’Agati V., et al. Acute kidney injury due to collapsing glomerulopathy following COVID-19 infection. Kidney Intern. Rep. 2020;5(6):940-45.
  49. Larsen C.P., Bourne T.D., Wilson J.D., et al. Collapsing glomerulopathy in a patient with COVID-19. Kidney Intern. Rep. 2020;5(6):935-39.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies